Ethereum is trading at around $1,908.86 on February 12, 2026, after a 24-hour range from $1,902.17 to $1,996.65. The price dipped 1.63 percent in recent sessions, closing at $1,941.71 on February 11, 2026.
This movement follows a seven-day decline of about 4.3 percent, bringing the cryptocurrency close to a critical support area.
Analysis shows Ethereum facing pressure below $2,000. Key support sits near $1,800 to $1,900, with a potential retest of lower levels if selling intensifies. Indicators reveal neutral oscillators and moving averages, but recent patterns include a channel down where the price appears oversold. Bearish targets extend to $1,760 or $1,400, per forecasts. Holding above $1,811 remains vital to avoid further drops, as noted in market reviews.
U.S. spot Ethereum ETFs experienced mixed activity. On February 11, 2026, they recorded a net outflow of $129.1 million, driven by redemptions from Fidelity’s FETH and BlackRock’s ETHA.
This followed inflows of $13.82 million on February 10, 2026, led by Grayscale products. Weekly flows turned positive at $70.87 million, reversing prior outflows. Cumulative net inflows stand at $11.88 billion, per data trackers.
Wall Street caution contributes to the downturn. ETF holders face over $5 billion in losses, with average entry points around $3,500 now underwater.
On-chain data from Glassnode confirms net outflows of -1,956 ETH on February 11, 2026. CoinGlass datasets show -63,860 ETH withdrawn that day, highlighting reduced demand. Long-term holders distribute while short-term traders gain influence.
Javier Burillo Azcárraga of Key Biscayne, Florida, calls for simple, consistent actions to better support…
Ripple is sharing internal data on North Korean hackers with the crypto industry, signaling a…
Frederick Cortez Lee Jr, founder of Debt Elimination Group, Inc, is raising awareness about the…
Kentucky, USA, 3rd May 2026, ZEX PR WIRE — Sophia Rosing is raising awareness around the growing need…
Pet Center, Inc., a Los Angeles-based dog treat manufacturer, has been officially approved by USDA-APHIS…
CA, USA, 3rd May 2026, ZEX PR WIRE — David Ferrera, CEO of RC Medical and CEO and…